SCXA Antikörper (full length)
Kurzübersicht für SCXA Antikörper (full length) (ABIN7878976)
Target
Alle SCXA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Bindungsspezifität
- full length
-
Verwendungszweck
- SCXA Antibody / Scleraxis (azide and preservative free)
-
Aufreinigung
- Protein A/G affinity
-
Immunogen
- Recombinant full-length human Basic helix-loop-helix transcription factor scleraxis protein was used as the immunogen for the SCXA antibody.
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
- Optimal dilution of the SCXA antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the SCXA antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- SCXA (Scleraxis (SCXA))
-
Andere Bezeichnung
- SCXA
-
Hintergrund
- Transcription factors are proteins that bind DNA adjacent to genes and control the production of mRNA transcripts. Scleraxis (basic helix-loop-helix transcription factor scleraxis) is a 201 amino acid protein that dimerizes with another bHLH protein to initiate transcription. Scleraxis is known to play a role in formation of mesoderm and somite-derived chondrogenic lineages. Scleraxis localizes to the nucleus and contains one bHLH domain. bHLH transcription factors, in general, function in cellular differentiation, proliferation, and oncogene regulation. The gene encoding Scleraxis maps to human chromosome 8, which consists of nearly 146 million base pairs, houses more than 800 genes and is associated with a variety of diseases and malignancies. Schizophrenia, bipolar disorder, Trisomy 8, Pfeiffer syndrome, congenital hypothyroidism, Waardenburg syndrome and some leukemias and lymphomas are thought to occur as a result of defects in specific genes that map to chromosome 8.
-
UniProt
- Q7RTU7
Target
-